Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-kB pathway

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 5, 2012, Pages 1134-1145

  Wang, Tao ^a   Wang, Xian Guo ^a   Xu, Jun Hua ^a   Wu, Xiang Peng ^a   Qiu, Hong Ling ^a   Yi, Hong ^a   Li, Wen Xin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cancer progression; NF B; TRAF2; Zinc finger protein

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA BINDING PROTEIN; I KAPPA B KINASE; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MYC PROTEIN; MYC PROTEIN, HUMAN; REPRESSOR PROTEIN; TCEAL1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; ZNF300 PROTEIN, HUMAN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMISTRY; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HELA CELL; HUMAN; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-6; INTERLEUKIN-8; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NEOPLASM METASTASIS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84860319840     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01388.x     Document Type: Article

References (40)

1. Miller J, McLachlan AD, Klug A. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. Embo J. 1985; 4: 1609-14.
2. Lee MS, Gippert GP, Soman KV, et al. Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science. 1989; 245: 635-7.
3. Gamsjaeger R, Liew CK, Loughlin FE, et al. Sticky fingers: zinc-fingers as protein-recognition motifs. Trends Biochem Sci. 2007; 32: 63-70.
4. Rubin GM, Yandell MD, Wortman JR, et al. Comparative genomics of the eukaryotes. Science. 2000; 287: 2204-15.
5. Laity JH, Lee BM, Wright PE. Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol. 2001; 11: 39-46.
6. Barbaux S, Niaudet P, Gubler MC, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet. 1997; 17: 467-70.
7. Ladomery M, Dellaire G. Multifunctional zinc finger proteins in development and disease. Ann Hum Genet. 2002; 66: 331-42.
8. De La Rosa-Velazquez IA, Rincon-Arano H, Benitez-Bribiesca L, et al. Epigenetic regulation of the human retinoblastoma tumour suppressor gene promoter by CTCF. Cancer Res. 2007; 67: 2577-85.
9. Song XT, Evel-Kabler K, Shen L, et al. A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat Med. 2008; 14: 258-65.
10. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumour locus. Cell. 1990; 60: 509-20.
11. Zhuang Z, Merino MJ, Vortmeyer AO, et al. Identical genetic changes in different histologic components of Wilms' tumours. J Natl Cancer Inst. 1997; 89: 1148-52.
12. Schmitz R, Hansmann ML, Bohle V, et al. TNFAIP3 (A20) is a tumour suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med. 2009; 206: 981-9.
13. Gebelein B, Fernandez-Zapico M, Imoto M, et al. KRAB-independent suppression of neoplastic cell growth by the novel zinc finger transcription factor KS1. J Clin Invest. 1998; 102: 1911-9.
14. Kuramoto K, Uesaka T, Kimura A, et al. ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells. Cancer Res. 2000; 60: 425-30.
15. Qi CF, Martensson A, Mattioli M, et al. CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells. Proc Natl Acad Sci USA. 2003; 100: 633-8.
16. 2 zinc finger gene ZNF300. Biochim Biophys Acta. 2004; 1676: 203-9.
17. Qiu H, Xue L, Gao L, et al. Identification of the DNA binding element of the human ZNF300 protein. Cell Mol Biol Lett. 2008; 13: 391-403.
18. Xue L, Qiu H, Ma J, et al. ZNF300, a recently identified human transcription factor, activates the human IL-2Rbeta promoter through the overlapping ZNF300/EGR1 binding site. Cell Mol Biol Lett. 2010; 15: 530-40.
19. Shao H, Zhu C, Zhao Z, et al. KRAB-containing zinc finger gene ZNF268 encodes multiple alternatively spliced isoforms that contain transcription regulatory domains. Int J Mol Med. 2006; 18: 457-63.
20. Ferguson LR, Philpott M, Dryland P. Nutrigenomics in the whole-genome scanning era: Crohn's disease as example. Cell Mol Life Sci. 2007; 64: 3105-18.
21. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-7.
22. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008; 454: 436-44.
23. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006; 441: 431-6.
24. Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004; 430: 694-9.
25. Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res. 2003; 283: 17-21.
26. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006; 25: 6680-4.
27. Tergaonkar V. NFkappaB pathway: a good signaling paradigm and therapeutic target. Int J Biochem Cell Biol. 2006; 38: 1647-53.
28. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003; 3: 11-22.
29. Rangarajan A, Weinberg RA. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer. 2003; 3: 952-9.
30. Meira LB, Bugni JM, Green SL, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest. 2008; 118: 2516-25.
31. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005; 5: 749-59.
32. Krig SR, Miller JK, Frietze S, et al. ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells. Oncogene. 2010; 29: 5500-10.
33. Liu TX, Becker MW, Jelinek J, et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Nat Med. 2007; 13: 78-83.
34. DiDonato JA, Hayakawa M, Rothwarf DM, et al. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997; 388: 548-54.
35. Freimoser FM, Jakob CA, Aebi M, et al. The MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5- diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities. Appl Environ Microbiol. 1999; 65: 3727-9.
36. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65: 55-63.
37. Guo MX, Wang D, Shao HJ, et al. Transcription of human zinc finger ZNF268 gene requires an intragenic promoter element. J Biol Chem. 2006; 281: 24623-36.
38. Agata Y, Matsuda E, Shimizu A. Two novel Kruppel-associated box-containing zinc-finger proteins, KRAZ1 and KRAZ2, repress transcription through functional interaction with the corepressor KAP-1 (TIF1beta/KRIP-1). J Biol Chem. 1999; 274: 16412-22.
39. Hagemeier C, Bannister AJ, Cook A, et al. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA. 1993; 90: 1580-4.
40. Kyriazis AP, Kyriazis AA, Scarpelli DG, et al. Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics. Am J Pathol. 1982; 106: 250-60.